CORD-19:867ebb2be2d466bcb35e5a7319708eaff39c4799 / 431395-431621 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T367","span":{"begin":0,"end":8},"obj":"Sentence"},{"id":"T368","span":{"begin":9,"end":226},"obj":"Sentence"}],"text":"Methods: To verify this hypothesis, freshly isolated platelets from healthy donors were treated with DENV type 1 recombinant NS1 from drosophila and were evaluated for markers of activation, cytokine secretion and aggregation."}

{"project":"CORD-19-Sentences","denotations":[{"id":"T41095","span":{"begin":0,"end":8},"obj":"Sentence"},{"id":"T7171","span":{"begin":9,"end":226},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Methods: To verify this hypothesis, freshly isolated platelets from healthy donors were treated with DENV type 1 recombinant NS1 from drosophila and were evaluated for markers of activation, cytokine secretion and aggregation."}

{"project":"Epistemic_Statements","denotations":[{"id":"T684","span":{"begin":0,"end":226},"obj":"Epistemic_statement"}],"text":"Methods: To verify this hypothesis, freshly isolated platelets from healthy donors were treated with DENV type 1 recombinant NS1 from drosophila and were evaluated for markers of activation, cytokine secretion and aggregation."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2297","span":{"begin":125,"end":128},"obj":"Disease"},{"id":"T58137","span":{"begin":125,"end":128},"obj":"Disease"}],"attributes":[{"id":"A2297","pred":"mondo_id","subj":"T2297","obj":"http://purl.obolibrary.org/obo/MONDO_0008104"},{"id":"A68177","pred":"mondo_id","subj":"T58137","obj":"http://purl.obolibrary.org/obo/MONDO_0008104"}],"text":"Methods: To verify this hypothesis, freshly isolated platelets from healthy donors were treated with DENV type 1 recombinant NS1 from drosophila and were evaluated for markers of activation, cytokine secretion and aggregation."}